Sanofi at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
Sanofi takes part in 9 sessions at Festival of Biologics 2026 in Basel. Its program centres on antibody and nanobody discovery, from screening antibody-making cells to computer-designed proteins. It also presents clinical results in asthma for lunsekimig, a nanobody that blocks two targets (TSLP and IL-13), and nanobodies engineered to stay in the blood longer.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
Sanofi Paris, France | |
Talk Tue Oct 13 14:10 Talk Tue Oct 13 14:10 Talk Tue Oct 13 15:10 Talk Tue Oct 13 17:10 Talk Tue Oct 13 17:50 Talk Wed Oct 14 11:30 Talk Wed Oct 14 14:50 Breaking the Nanobody® half-life ceiling: pH-dependent Nanobody® molecules targeting a distinct FcRn epitope enable superior pharmacokinetics and broad therapeutic applications A small antibody fragment that binds a new site on the receptor controlling protein recycling, letting the drug last longer in the body. Talk Thu Oct 15 12:40 |
Instantly find 20 buyers from Sanofi
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction